Blogopmaak

PhD Position in treatment-response fluid biomarkers for ASO treatments

The Doctoral Training Network “Medicine Made to Measure” (MMM) is looking for a PhD student for the Translational Genomics of Neurodegenerative Diseases division at the University of Tübingen, Germany.


The PhD candidate will be supported for 3 years by the European Union Horizon Marie Sklodowska Curie Actions programme. The successful applicant will attend regular training courses with other MMM PhD students and will be given the opportunity to gain experience at MMM partner institutes, such as Leiden University Medical Center.


If you are interested, carefully read the job description and send your application before 18th August to s

selina.reich@uni-tuebingen.de.


posted on August 7, 2024

by duda-wsm 26 Sept, 2024
Two new DCRT papers have been published online
by duda-wsm 08 Aug, 2024
Team DCRT went for its annual outing to Leiden's escape rooms
by duda-wsm 08 Aug, 2024
N=1 Collaborative is looking for communication trainees
by duda-wsm 07 Aug, 2024
PhD Position in treatment-response fluid biomarkers for ASO treatments
by duda-wsm 07 Aug, 2024
Short report of the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
by duda-wsm 31 Jul, 2024
DCRT travel grants awarded to 3 PhD students
Dr. Marlen Lauffer, senior researcher at the DCRT, at the Genomics England research summit
by duda-wsm 10 Jul, 2024
Dr Marlen Lauffer, a senior researcher at the Dutch Center for RNA Therapeutics, was invited to give a talk at the Genomics England research summit in London on the 9th of July. She presented DCRT's work on the identification of genes and diseases and guidelines for patient selection.
by duda-wsm 01 May, 2024
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
by duda-wsm 22 Apr, 2024
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
by duda-wsm 10 Apr, 2024
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
More posts
Share by: